Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

July 7, 2021, 8:20 a.m. EDT

Dare Bioscience stock rockets after new $49 million grant from Bill & Melinda Gates Foundation

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Dare Bioscience Inc. (DARE)
  • X
    iShares Biotechnology ETF (IBB)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Dare Bioscience Inc. /zigman2/quotes/203460984/composite DARE +2.61% rocketed 63.1% in very active premarket trading Wednesday, after the California-based health care company said it was awarded a new grant of up to $48.95 million from the Bill & Melinda Gates Foundation. Trading volume spiked up to 18.1 million shares, compared with the full-day average of about 3.7 million shares. The new grant is to support the development and preclinical activities to advance Dare's investigational reversible contraceptive, DARE-LARC1, toward testing in humans. As part of the grant agreement, DAre agreed to make DARE-LARC1 and any other products available at an affordable price to people in developing countries, or in support of the U.S. educational system and public libraries. The stock has lost 10.6% over the past three months through Tuesday, while the iShares Nasdaq Biotechnology ETF /zigman2/quotes/206189322/composite IBB +1.46% has gained 9.4% and the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.24% has tacked on 6.5%.

/zigman2/quotes/203460984/composite
US : U.S.: Nasdaq
$ 1.22
+0.03 +2.61%
Volume: 256,114
July 5, 2022 2:33p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$100.81 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/206189322/composite
US : U.S.: Nasdaq
$ 121.93
+1.76 +1.46%
Volume: 2.42M
July 5, 2022 2:40p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,816.27
-9.06 -0.24%
Volume: 1.60B
July 5, 2022 2:41p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.